Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-08-13
1993-02-02
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 530325, 530326, A61K 3700, A61K 3702, C07K 500, C07K 700
Patent
active
051838052
ABSTRACT:
A biologically active cyclic synthetic peptide analog having an amino acid sequence similar to that of native epidermal growth factor between amino acids 32-48 is revealed. The peptide has been found to mimic certain biological activities of intact native epidermal growth factor (EGF). The EGF peptide analogs of the present invention include at least one sulfhydryl bond between two cysteines of the peptide containing block termini. The peptides comprise the end of the B-loop and the C-loop characteristic of the native form of the epidermal growth factor peptide. The biological activity of the peptide provides for methods of using the peptide as an agent in wound healing and also in cancer therapy. More particularly, the described peptides are used in cancer therapeutic applications and in the promotion of wound healing, especially burn wounds and peptic ulcer disease. Methods of preparing and using the described bioactive EGF analog peptides are also disclosed. Both the D- and L- forms of the peptides' amino acids are within the scope of the described biologically active peptides.
REFERENCES:
patent: 4686283 (1987-08-01), Nestor, Jr. et al.
International Search Report (1992).
Mably et al. (1985), Chemical Abstracts, 102(3), Abstract 17757z.
Mortsch et al. (1984), Chemical Abstracts, 101(3), Abstract 17554k.
WO, A1 8901489-Commonwealth Scientific and Industrial Research Organization (1989).
WO, A1 8501284-Komoriya, Akira (1985).
Cooke, R. M. et al., (1987), Nature, 327:339-341.
Komoriya et al., (1984), Proc. Natl. Acad. Sci. USA, 81:1351-1355.
Heath et al., (1986), Proc. Natl. Acad. Sci. USA, 83:6367-6371.
Gregory et al., (1975), Nature, 257:325-327.
Cohen et al., (1975), Proc. Natl. Acad. Sci. USA, 73:1317-1321.
Simpson et al., (1985), Eur. J. Biochem., 153:629-637.
Engler et al., (1988), J. Biol. Chem., 253(25):12384-12390.
Tam et al., (1986), Proc. Natl. Acad. Sci. USA, 83(21):8082-8086.
Hudgins et al., (1988), Cancer Res. 48(6):1428-1434.
Hannauske et al., (1986), Cancer Res., 48(11):5567-5570.
Nestor et al., (1985), Biochem. Biophys. Res. Commun., 129:226-232.
Bell et al., (1986), Nucleic Acids Research, 14(21):8427-8446.
Blick Mark
Lee Jin S.
Board of Regents , The University of Texas System
Davenport A. M.
Lee Lester L.
LandOfFree
Bioactive EGF peptides for promotion of tissue regeneration and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive EGF peptides for promotion of tissue regeneration and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive EGF peptides for promotion of tissue regeneration and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-6947